Enhanced Glioblastoma Targeting and Penetration: Extracellular Matrix Remodeling by Collagenase-Functionalized Ferumoxytol Nanoparticles
Nano Letters · 19.08.2026 · 26 (32) · 10607-10616
DOI: 10.1021/acs.nanolett.6c01219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 29.07.2026. Verfasst von Jie Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, California94305, United States. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Matrix, Collagenases, Ferrosoferric Oxide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, Foundation for the National Institutes of Health, NCI NIH HHS.
Abstract (Originalsprache)
Glioblastoma (GBM) contains a dense collagen-IV-rich extracellular matrix (ECM) that restricts intratumoral transport of therapeutic agents. To overcome this barrier, we engineered protease-responsive, collagenase-functionalized theranostic nanoparticles (TNP-collagenase) by conjugating collagenase-IV to the FDA-approved iron oxide nanoparticle ferumoxytol through a cathepsin B-cleavable linker, enabling tumor-specific enzyme activation. TNP-collagenase retained high MRI relaxivity and exhibited minimal cytotoxicity. In 3D tumor spheroids, TNP-collagenase significantly enhanced nanoparticle penetration compared with ferumoxytol alone. In an orthotopic U87MG mouse model, MRI demonstrated greater tumor accumulation of TNP-collagenase, reflected by significantly reduced tumor T2 relaxation times. TNP-collagenase combined with temozolomide (TMZ) induced significant tumor regression compared with PBS + TMZ and ferumoxytol + TMZ. Histological analyses confirmed degradation of perivascular collagen-IV and improved intratumoral distribution of therapeutics. These results establish enzyme-activated ECM remodeling as a nanomedicine strategy to enhance drug delivery and therapeutic efficacy in GBM while enabling noninvasive imaging of treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, California94305, United States.
ORCID-Profile: Jie Wang
Förderung
- European Commission
- Foundation for the National Institutes of Health
- NCI NIH HHS
- NICHD NIH HHS
- U.S. Department of Health and Human Services
Zitieren
APA
Wang, J., Annio, G., Duwa, R., Suryadevara, V., Chang, E., & Daldrup-Link, H. (2026). Enhanced Glioblastoma Targeting and Penetration: Extracellular Matrix Remodeling by Collagenase-Functionalized Ferumoxytol Nanoparticles. Nano Letters, 26(32), 10607-10616. https://doi.org/10.1021/acs.nanolett.6c01219
Vancouver
Wang J, Annio G, Duwa R, Suryadevara V, Chang E, Daldrup-Link H. Enhanced Glioblastoma Targeting and Penetration: Extracellular Matrix Remodeling by Collagenase-Functionalized Ferumoxytol Nanoparticles. Nano Letters. 2026;26(32):10607-10616. doi:10.1021/acs.nanolett.6c01219
BibTeX
@article{Wang2026,
author = {Wang, Jie and Annio, Giacomo and Duwa, Ramesh and Suryadevara, Vidyani and Chang, Edwin and Daldrup-Link, Heike},
title = {Enhanced Glioblastoma Targeting and Penetration: Extracellular Matrix Remodeling by Collagenase-Functionalized Ferumoxytol Nanoparticles},
journal = {Nano Letters},
year = {2026},
volume = {26},
number = {32},
pages = {10607--10616},
doi = {10.1021/acs.nanolett.6c01219}
}
EUVIMED